MedTrace Logo

Integrated Approaches for Identifying Molecular Targets in Alcoholic Hepatitis

NCT02075918 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 376

Last updated 2019-06-10

No results posted yet for this study

Summary

Purpose: To improve the diagnosis and assessment of severity of acute alcoholic hepatitis Participants: Patients admitted to one of ten centers with acute alcoholic hepatitis Procedures (methods): Consecutive patients admitted with acute alcoholic hepatitis will be enrolled in an NIH U01 study of acute alcoholic hepatitis where liver tissue, blood and stool will be collected to discover and validate factors associated with diagnosis, severity of disease and survival.

Conditions

  • Alcoholic Hepatitis
  • Control Patients

Sponsors & Collaborators

  • National Institute on Alcohol Abuse and Alcoholism (NIAAA)

    collaborator NIH

  • University of Wisconsin, Madison

    collaborator OTHER

  • King's College London

    collaborator OTHER

  • Veterans Medical Research Foundation

    collaborator OTHER

  • Hospital Vall d'Hebron

    collaborator OTHER

  • Institut National de la Santé Et de la Recherche Médicale, France

    collaborator OTHER_GOV

  • Yale University

    collaborator OTHER

  • Columbia University

    collaborator OTHER

  • Weill Medical College of Cornell University

    collaborator OTHER

  • University of Alberta

    collaborator OTHER

  • TecSalud Investigación Clínica

    collaborator OTHER

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Ramon Bataller, MD · University of Pittsburgh

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-05-31
Primary Completion
2019-05-31
Completion
2019-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02075918 on ClinicalTrials.gov